Private Equity
Philadelphia-based 1315 Capital has raised $300 million for its fund, 1315 Capital II, according to a regulatory filing. The firm invests in pharmaceutical, medical technology, and healthcare service companies, according to its website. It is led by Adele Oliva, Michael Koby, and Brian Schwenk. The fund closed at its hard cap of $300 million, exceeding its $250 million target, according to a press release. The filing lists 57 investors.
1 min read · 15 February 2018
2 min read · 14 February 2018
Elsewhere Partners is raising a venture fund targeted at $100 million, according to a regulatory filing. The Austin, Texas, based firm launched in September 2017 and is led by Chris Pacitti and John Thornton, both veterans of Austin Ventures.
1 min read · 13 February 2018
2 min read · 13 February 2018
2 min read · 07 February 2018
6 min read · 07 February 2018
Hinge Capital is raising a fund targeted at $80 million, according to a regulatory filing. The firm, based in Encinitas, California, is led by Ryan Swagar and Brandon Zeuner, who are both managing partners at Venture51, an early-stage venture firm based in San Diego. The filing is an amended version of a previous filing that listed the fund's targeted amount at $200 million. Hinge Capital does not appear to have a website. The filing lists no investors.
1 min read · 31 January 2018
Polychain Ventures is raising a venture fund of indefinite size, according to a regulatory filing. The San Francisco-based firm is managed by Olaf Carlson-Wee, who manages the hedge fund Polychain Capital, which invests in blockchain technology assets. Polychain Ventures does not yet appear to have a website. The filing lists no investors.
1 min read · 30 January 2018
2 min read · 30 January 2018
2 min read · 25 January 2018
